Silvergate Pharmaceuticals Inc

General

Total Cases13

Active Cases--

Patents--

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

silvergatepharma.com

silvergate-pharmaceuticals

silvergate-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

L4

E

PTAB

L5

E

CAFC

L3

B

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
04/05/24	Silvergate Pharma Inc v. Bionpharma Inc 1:19-CV-01067 ( D. DE )	NOTICE requesting Clerk to remove Granville C. Kaufman as co-counsel.. (Dellinger, Megan) (Entered: 04/05/2024)
10/06/23	Silvergate Pharma Inc v. Bionpharma Inc 1:19-CV-01067 ( D. DE )	NOTICE requesting Clerk to remove Ty W. Callahan as co-counsel. Reason for request: No longer with firm. (Dellinger, Megan) (Entered: 10/06/2023)
08/08/23	Silvergate Pharma Inc v. Bionpharma Inc 1:18-CV-01962 ( D. DE )	Official Transcript of Telephone Conference held on 08/02/2023 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber TK Transcribers, Contact: 609-440-2177. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 8/29/2023. Redacted Transcript Deadline set for 9/8/2023. Release of Transcript Restriction set for 11/6/2023. (smg) (Entered: 08/08/2023) Official Transcript of Telephone Conference held on 08/02/2023 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber TK Transcribers, Contact: 609-440-2177. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 8/29/2023. Redacted Transcript Deadline set for 9/8/2023. Release of Transcript Restriction set for 11/6/2023. (smg) (Entered: 08/08/2023)
08/02/23	Silvergate Pharma Inc v. Bionpharma Inc 1:18-CV-01962 ( D. DE )	Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Status Conference held on 8/2/2023. (Court Reporter Jimmy Cruz.) (mpb) (Entered: 08/02/2023)
07/20/23	Silvergate Pharma Inc v. Bionpharma Inc 1:18-CV-01962 ( D. DE )	ORDER, a Status Conference on Defendant's Motion for Attorney Fees (D.I. 322 in 18-cv-1962 and D.I. 309 in 19-cv-1067) is scheduled for Wednesday, August 2, 2023 at 2:30 p.m. The conference will be conducted via telephone and held on the record. Counsel should dial in as follows: (1) Call: 888-684-8852; (2) Enter access code: 2187450#; (3) Press # to enter as a participant. Signed by Judge Mitchell S. Goldberg on 7/20/2023. Associated Cases: 1:18-cv-01962-MSG, 1:19-cv-01067-MSG(twk) (Entered: 07/20/2023) ORDER, a Status Conference on Defendant's Motion for Attorney Fees (D.I. 322 in 18-cv-1962 and D.I. 309 in 19-cv-1067) is scheduled for Wednesday, August 2, 2023 at 2:30 p.m. The conference will be conducted via telephone and held on the record. Counsel should dial in as follows: (1) Call: 888-684-8852; (2) Enter access code: 2187450#; (3) Press # to enter as a participant. Signed by Judge Mitchell S. Goldberg on 7/20/2023. Associated Cases: 1:18-cv-01962-MSG, 1:19-cv-01067-MSG(twk) (Entered: 07/20/2023)
07/20/23	Silvergate Pharma Inc v. Bionpharma Inc 1:19-CV-01067 ( D. DE )	ORDER, a Status Conference on Defendant's Motion for Attorney Fees (D.I. 322 in 18-cv-1962 and D.I. 309 in 19-cv-1067) is scheduled for Wednesday, August 2, 2023 at 2:30 p.m. The conference will be conducted via telephone and held on the record. Counsel should dial in as follows: (1) Call: 888-684-8852; (2) Enter access code: 2187450#; (3) Press # to enter as a participant. Signed by Judge Mitchell S. Goldberg on 7/20/2023. Associated Cases: 1:18-cv-01962-MSG, 1:19-cv-01067-MSG(twk) (Entered: 07/20/2023) ORDER, a Status Conference on Defendant's Motion for Attorney Fees (D.I. 322 in 18-cv-1962 and D.I. 309 in 19-cv-1067) is scheduled for Wednesday, August 2, 2023 at 2:30 p.m. The conference will be conducted via telephone and held on the record. Counsel should dial in as follows: (1) Call: 888-684-8852; (2) Enter access code: 2187450#; (3) Press # to enter as a participant. Signed by Judge Mitchell S. Goldberg on 7/20/2023. Associated Cases: 1:18-cv-01962-MSG, 1:19-cv-01067-MSG(twk) (Entered: 07/20/2023)
05/30/23	Azurity Pharma Inc v. Alkem Laboratories Ltd 1:19-CV-02100 ( D. DE )	NOTICE requesting Clerk to remove Evan Sumner as co-counsel. Reason for request: No Longer with Firm. (Dellinger, Megan) (Entered: 05/30/2023)
02/28/23	Azurity Pharma Inc v. Alkem Laboratories Ltd 1:19-CV-02100 ( D. DE )	NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 216 Notice of Appeal (Federal Circuit) filed by Azurity Pharmaceuticals, Inc. USCA Case Number 2023-1540 (mpb) (Entered: 02/28/2023)
02/15/23	Azurity Pharma Inc v. Alkem Laboratories Ltd 1:19-CV-02100 ( D. DE )	Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 216 Notice of Appeal (Federal Circuit). (mpb) (Entered: 02/15/2023)
02/15/23	Azurity Pharma Inc v. Alkem Laboratories Ltd 1:19-CV-02100 ( D. DE )	Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 216 Notice of Appeal (Federal Circuit). (mpb) (Entered: 02/15/2023)